Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma

European Journal of Ophthalmology

Volumn 14, Issue 3, 2004, Pages 211-219

  Erkin, Esin F ^a,b   Tarhan, S ^a   Kayikcioglu O R ^a   Deveci, H ^a   Guler C ^a   Goktan C ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Betaxolol; Blood flow; Color Doppler imaging; Latanoprost; Primary open angle glaucoma; Visual fields

Indexed keywords

BETAXOLOL; LATANOPROST; ANTIHYPERTENSIVE AGENT; EYE DROPS; PROSTAGLANDIN F;

ARTICLE; BLOOD FLOW VELOCITY; CILIARY ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE BLOOD FLOW; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; PERIMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ARTERY; STATISTICAL ANALYSIS; VISUAL FIELD; BLOOD FLOW; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

ANTIHYPERTENSIVE AGENTS; BETAXOLOL; BLOOD FLOW VELOCITY; CILIARY ARTERIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; REGIONAL BLOOD FLOW; RETINAL ARTERY; TONOMETRY, OCULAR; ULTRASONOGRAPHY, DOPPLER, COLOR; VISUAL FIELDS;

EID: 3142519732     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400305     Document Type: Article

References (51)

1. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000; 130: 429-40.
2. Heijl A, Leske CL, Bengtsson B, Hyman L, Bengtsson B, Hussein M, for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol 2002; 120: 1268-79.
3. Rankin SJA. Color Doppler imaging of the retrobulbar circulation in glaucoma. Surv Ophthalmol 1999; 43 (Suppl): S176-82.
4. Soltau JB, Zimmerman TJ. Changing paradigms in the medical treatment of glaucoma. Surv Ophthalmol 2002; 47 (Suppl): S2-5.
5. Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21: 359-93.
6. Nicolela MT, Drance SM, Rankin SJ. Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss. Am J Ophthalmol 1996; 121: 502-10.
7. Turaçli ME, Özden RG, Bardak Y, Yazicioǧlu KM. Normal tansiyonlu glokomda betaksololün görme alani ve okuler kan akimi üzerindeki erken dönem etkisi. T Klin Oftalmoloji 1995; 4: 345-9.
8. Harris A, Spaeth GL, Sergott RC, Katz JL, Cantor LB, Martin BJ. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol 1995; 120: 168-75.
9. Boles Carenini AB, Sibour G, Boles Carenini B. Differences in the long term effect of timolol and betaxolol on the pulsatile ocular blood flow. Surv Ophthalmol 1994; 38 (Suppl): S118-24.
10. Hoste AM. In vitro studies of the effects of β-adrenergic drugs on retinal and posterior ciliary microarteries. Surv Ophthalmol 1999; (Suppl): S183-90.
11. Hester RK, Chen Z, Becker EJ, McLaughlin M, DeSantis L. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Surv Ophthalmol 1994; 38: (Suppl): S125-34.
12. Gupta A, Chen HC, Rassam SMB, Kohner EM. Effect of betaxolol on the retinal circulation in eyes with ocular hypertension study. Eye 1994; 8: 668-71.
13. Hesse RJ. Color Doppler ultrasound measurement of beta-blocker response in normal tension glaucoma. Neuro-Ophthalmol 1995; 15: 259-63.
14. Georgopoulos GT, Diestelhorst M, Fisher R, Ruokonen P, Krieglstein GK. The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand 2002; 80: 54-8.
15. Tamaki Y, Nagahara M, Araie M, Tomita K, Sandoh S, Tomidokoro A. Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther 2001; 17: 403-11.
16. Ishii K, Tomidokoro A, Nagahara M, et al. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci 2001; 42: 2957-63.
17. Geyer O, Man O, Weintraub M, Silver DM. Acute effects of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol 2001; 131: 198-202.
18. Sponsel WE, Mensah J, Kiel JW, et al. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthalmol 2000; 130: 151-9.
19. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999; 13: 31-4.
20. Vetrugno M, Cantatore F, Gigante G, Cardia L. Latanoprost 0.005% in POAG: effects on IOP and ocular blood flow. Acta Ophthalmol Scand 1998; 227 (Suppl): S40-1.
21. Liu CJ, Ko YC, Chou JC, Hsu WM, Liu JH. Effect of latanoprost 0.005% and brimonidine tartrate 0.2% on pulsatile ocular blood flow in normal tension glaucoma. Br J Ophthalmol 2002; 86: 1236-9.
22. Aburn NS, Sergott RC. Orbital colour Doppler imaging. Eye 1993; 7: 639-47.
23. Greeenfield DS, Heggerick PA, Hedges III TR. Color Doppler imaging of normal orbital vasculature. Ophthalmology 1995; 102: 1598-605.
24. Guthoff RF, Berger RW, Winkler P, Helmke K, Chumbley LC. Doppler ultrasonography of the ophthalmic and central retinal vessels. Arch Ophthalmol 1991; 109: 532-6.
25. Lieb WE, Cohen SM, Merton AD, Shields JA, Mitchell DG, Goldberg BB. Color Doppler imaging of the eye and orbit. Technique and normal vascular anatomy. Arch Ophthalmol 1991; 109: 527-31.
26. Williamson TH, Haris JA. Color Doppler ultrasound imaging of the eye and orbit. Surv Ophthalmol 1996; 40: 255-67.
27. Turaçli ME, Özden RG, Gürses MA. The effect of betaxolol on ocular blood flow and visual fields in patients with normotension glaucoma. Eur J Ophthalmol 1998; 8: 62-6.
28. Rankin SJ, Drance SM, Buckley AR, Walman BE. Visual field correlations with color Doppler studies in open angle glaucoma. J Glaucoma 1996; 5: 15-21.
29. Harris A, Williamson TH, Martin B. Test/retest reproducibility of color Doppler imaging assessment of blood flow velocity in orbital vessels. J Glaucoma 1995; 4: 281-6.
30. Kaiser HJ, Schötzau A, Flammer J. Blood-flow velocities in the extraocular vessels in normal volunteers. Am J Ophthalmol 1996; 122: 364-70.
31. Talusan ED, Schwartz B, Wilcox LM. Fluorescein angiography of the optic disc. Arch Ophthalmol 1980; 98: 1579-87.
32. Hitchings RA, Spaeth GL. Fluorescein angiography in chronic simple and low-tension glaucoma. Br J Ophthalmol 1977; 61: 126-32.
33. Spaeth GL. Fluorescein angiography: its contributions towards understanding the mechanisms of visual loss in glaucoma. Trans Am Ophthalmol Soc 1975; 73: 491-553.
34. Kaiser HJ, Flammer J, Stumpfig D, Hendrickson P. Long-term visual field follow-up of glaucoma patients treated with beta-blockers. Surv Ophthalmol 1994; 38 (Suppl): S156-9.
35. Montanari P, Marangoni P, Oldani A, Ratiglia R, Raiteri M, Berardinelli L. Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%. Eur J Ophthalmol 2001; 11: 240-4.
36. Messmer C, Flammer J, Stumpfig D. Influence of betaxolol and timolol on the visual fields of patients with glaucoma. Am J Ophthalmol 1991; 112: 678-81.
37. Hoste AM, Sys SU. The relaxant action of betaxolol on isolated bovine retinal microarteries. Curr Eye Res 1994; 13: 483-7.
38. Drance SM. A comparison of the effects of betaxolol, timolol and pilocarpine on visual function in patients with open-angle glaucoma. J Glaucoma 1998; 7: 247-52.
39. Araie M, Azuma I, Kitazawa Y. Influence of topical betaxolol and timolol on visual fields in Japanese open-angle glaucoma patients. Jpn J Ophthalmol 2002; 47: 199-207.
40. Rainer G, Dorner GT, Garhofer G, Vass C, Pfleger T, Schmetterer L. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow. Ophthalmologica 2003; 217: 288-93.
41. Hoste AM. Reduction of IOP with latanoprost. Ophthalmology 1997; 104: 895-7.
42. Rulo AH, Hoyng PFJ. Authors reply to letter of A. Hoste. Ophthalmology 1997; 104: 896-7.
43. Kimura T, Yoshida Y, Toda N. Mechanisms of relaxation induced by prostaglandins in isolated canine uterine arteries. Am J Obstet Gynecol 1992; 167: 1409-16.
44. Maigaard S, Forman A, Andersonn KE. Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit. Acta Physiol Scand 1986; 128: 33-40.
45. α, and latanoprost acid on isolated ocular blood vessels in vitro. J Ocul Pharmacol Ther 1998; 14: 119-28.
46. Stjernschantz J, Selen G, Astin M, Karlsson M, Resul B. Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye. Arch Ophthalmol 1999; 117: 1363-7.
47. Brogiolo G, Flammer J, Haefliger IO. Latanoprost is a vasoconstrictor in isolated porcine ciliary arteries. Klin Monatsbl Augenheilkd 2001; 218: 373-5.
48. Nicolela MT, Buckley AR, Walman BE, Drance SM. A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels. Am J Ophthalmol 1996; 122: 784-9.
49. Maurice DM. Drug delivery to the posterior segment from the drops. Surv Ophthalmol 1999; 47 (Suppl): S41-58.
50. Sponsel WE, Terry S, Khuu HD, Lam KW, Frenzel H. Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy. Surv Ophthalmol 1999; 43 (Suppl): S210-3.
51. Trible JR, Sergott RC, Spaeth GL. Trabeculectomy is associated with retrobulbar hemodynamic changes: a color Doppler analysis. Ophthalmology 1994; 101: 340-51.